Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease

Youngshim Choi; Yinyan Ma; Samson Tom; Alla Danilkovitch; Liqing Yu

PMC · DOI:10.3389/fbioe.2025.1642526·June 26, 2025

Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease

Youngshim Choi, Yinyan Ma, Samson Tom, Alla Danilkovitch, Liqing Yu

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Species1

Rodentia(rodent · order)

Diseases4

metabolic dysfunction hepatic inflammation steatotic liver disease fibrosis

Figures1

Click any figure to enlarge with its caption.

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsLiver Disease Diagnosis and Treatment